Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02460146 · ClinicalTrials.gov registry record · Phase 1
PK and PD of Sequential Multiple Ascending, Repeat Doses of Oral CXA-10 in Healthy Obese Male Subjects
A Phase 1 study, sponsored by Complexa.
- Completed
- Registry status
- Phase 1
- Development phase
- 43
- Enrollment target
NCT02460146 is a Phase 1 study that has completed, run by Complexa. The registered enrollment target is 43 participants.
The verdict
NCT02460146, a Phase 1 study, has completed, sponsored by Complexa.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 43 participants
- Enrollment target
Study Summary
The main purpose of this trial is to demonstrate the safety, tolerability and pharmacokinetics (PK) of CXA-10 and its metabolite(s) administered as multiple ascending oral doses over 14 days to healthy obese male volunteers.
Interventions
- DRUG CXA-10
- OTHER CXA-10 placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2015-04 |
| Est. Completion | 2015-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02460146
The ClinicalTrials.gov registry entry for NCT02460146 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Complexa, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which CXA-10 is the first listed.
NCT02460146 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02460146 about?
NCT02460146 is a clinical study titled "PK and PD of Sequential Multiple Ascending, Repeat Doses of Oral CXA-10 in Healthy Obese Male Subjects". The main purpose of this trial is to demonstrate the safety, tolerability and pharmacokinetics (PK) of CXA-10 and its metabolite(s) administered as multiple ascending oral doses over 14 days to healthy obese male volunteers.
What is the current status of trial NCT02460146?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 43 participants. The study started on 2015-04. Estimated completion is 2015-10.
What interventions are being tested in trial NCT02460146?
The interventions under investigation include: CXA-10 (DRUG), CXA-10 placebo (OTHER).
Who is sponsoring clinical trial NCT02460146?
This trial is sponsored by Complexa, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.